PAVmed distributes 3.33M Lucid Diagnostics shares as special dividend; warrant price adjusted

PAVmed Inc.

PAVmed distributed 3,331,747 shares of Lucid Diagnostics common stock as a special pro rata dividend to common and preferred stockholders.
Each PAVmed share entitled to 0.37709668 Lucid Diagnostics shares based on record date January 15, 2024.
After distribution, PAVmed retains approx. 65.2% ownership of Lucid Diagnostics; 6.9% distributed.
Exercise price of Series Z Warrants reduced from $24.00 to $23.48 per share due to dividend fair value of $0.52.
Senior convertible note holders waived participation in the distribution; no fractional shares issued.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.